Oncothyreon to present at Rodman & Renshaw Global Healthcare Conference

About this update from Cascade Copper Corp.

[{"type":"text","content":"\n\n\n\nSEATTLE, WA, Sept. 3 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX: ONY)\nannounced today that Robert Kirkman, M.D., President and Chief Executive\nOfficer, will present at the Rodman & Renshaw 11th Annual Healthcare\nConference taking place Sept. 9-11, 2009 in New York.\n\n\nDr. Kirkman will present at 2 p.m. Eastern Time on Thursday, Sept. 10. A\nlive and archived webcast of the presentation will be accessible at\nhttp://www.wsw.com/webcast/rrshq15/onty or by visiting the Oncothyreon website\nwww.oncothyreon.com under the "News & Events" section.\n\n\nAbout Oncothyreon\n\n\nOncothyreon is a biotechnology company specializing in the development of\ninnovative therapeutic products for the treatment of cancer. Oncothyreon's\ngoal is to develop and commercialize novel synthetic vaccines and targeted\nsmall molecules that have the potential to improve the lives and outcomes of\ncancer patients. For more information, visit www.oncothyreon.com.\n\n\n","length":1029,"tagName":"div"}]

More updates from Cascade Copper Corp.